RYTM earnings date and last-quarter result: last quarter beat, P/E -33.22. Updated 2026-07-23.
Rhythm Pharmaceuticals (RYTM) Research Hub
Rhythm Pharmaceuticals (RYTM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 89.47 USD (+0.22%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -33.22, market cap 7.08B. This hub links to the full technical, earnings and options research available for RYTM.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 89.47 USD (+0.22%) |
| 52-week range | 85.38 USD – 119.75 USD |
| Trend regime | Range |
| 14-day RSI | 47 (Neutral) |
| Trailing P/E | -33.22 |
| Market cap | 7.08B |
| Dividend yield | 0.00% |
Available research for RYTM
Covered Call on RYTM: how it works, illustrative setup around the real 89.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RYTM: how it works, illustrative setup around the real 89.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RYTM: how it works, illustrative setup around the real 89.47 USD price, max profit/loss, breakeven and when to use it. Educational.
RYTM technical analysis: range, last 89.47 USD, RSI 47, 52w range 85.38 USD–119.75 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is RYTM in?
Rhythm Pharmaceuticals (RYTM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is RYTM in an uptrend or downtrend?
As of 2026-10-26, RYTM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RYTM's trailing P/E ratio?
RYTM's trailing P/E is -33.22, with a market cap of 7.08B. See the earnings research page for full valuation detail.